Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines

Related Experiment Video

Updated: May 14, 2026

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

Rui Sun1, Yuqin Liu

  • 1Department of Pathology; Institute of Basic Medical Sciences; Chinese Academy of Medical Sciences; School of Basic Medicine; Peking Union Medical College; Beijing, P.R. China.

Human Vaccines & Immunotherapeutics
|February 13, 2013
PubMed

Insights

Listeriolysin O (LLO) shows promise as a cancer immunotherapy agent and in anti-tumor vaccines due to its immune-modulating and adjuvant properties. This pore-forming toxin aids in bacterial escape and multiplication, while also stimulating T cell responses.

Area of Science:

  • Immunology
  • Microbiology
  • Cancer Research

Background:

  • Listeria monocytogenes produces listeriolysin O (LLO), a pore-forming toxin.
  • LLO facilitates bacterial phagosomal escape and multiplication during infection.
  • LLO is recognized for its role in modulating immune responses.

Purpose of the Study:

  • To explore the potential of LLO in cancer immunotherapy.
  • To investigate LLO's adjuvant properties for anti-tumor vaccine development.
  • To understand LLO's mechanism in modulating immune tolerance and memory.

Main Methods:

  • Analysis of LLO's cytotoxicity.
  • Evaluation of LLO's adjuvant properties in vaccine contexts.
  • Characterization of LLO as a source of T cell epitopes.

Main Results:

  • LLO exhibits potent, cell type-non-specific toxicity.
  • LLO provides dominant CD4(+) and CD8(+) T cell epitopes.
  • LLO demonstrates non-specific adjuvant properties beneficial for anti-tumor vaccines.

Conclusions:

  • LLO is effective as a cancer immunotherapeutic agent.
  • LLO's adjuvant properties support the development of efficacious anti-tumor vaccines.
  • LLO holds promise for overcoming immune tolerance in cancer treatment.
Keywords:
LLOListeriaanti-tumor vaccinecancer immunotherapycytotoxicityimmunogenicitypore-forming toxin

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells10:07

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells

Published on: January 7, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...